Post-translational protein modification plays an essential role in facilitating signal transduction regulation of gene expression. Protein modification by phosphorylation, acetylation, or methylation helps control the proper timing and sequence of events during embryogenesis; therefore, it is not surprising that defective modifications of these proteins can be important causes in the development of many types of congenital diseases. Accumulating evidence illustrates the importance of post-translational lipid modifications for regulating protein function. One example is the cholesterol and palmitoyl modification of Sonic hedgehog (Shh), which guides this protein's biogenesis, cellular trafficking, and functionality. 1 Shh is a highly conserved fetal morphogen that plays a central role in cell proliferation, differentiation, and embryonic patterning by activating the Hedgehog (Hh) signal pathway. 2, 3 The 45 kDa Shh precursor protein undergoes modification by auto-processing, followed by covalent linkage of cholesterol to the N-terminal proteolytic product. 4 This mature, cholesterol-modified protein (19 kDa) can be transported to the cell membrane for secretion. 5 Once secreted, the cholesterol-modified Shh ligand can initiate signal transduction by binding to its receptor, Patched (Ptc). Upon binding, Ptc relieves the inhibition of the signal transducer, Smoothened (Smo), 6 which then activates Gli transcription factors by uncoupling them from the negative regulator, Suppressor of Fused. 7 Gli is subsequently translocated to the nucleus and regulate expression of target genes including Ptc, 8 Gli1 9 itself and Nkx2.2.
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During embryogenesis, Shh is expressed specifically in Hensen's node, the floor plate of the neural tube, the cardiac mesenchyme, the early gut endoderm, the posterior portion of the limb buds, and throughout the notochord. As it is a morphogen, Shh also affects the development of tissues that are distal to where it is produced. Shh is apparently a key inductive signal for patterning of the ventral neural tube 11, 12 the anterior-posterior limb axis, 13 and the ventral somites. 14 In humans, one severe phenotype caused by mutations in Shh, or other components of Hh signaling, is holoprosencephaly (HPE), 15 a disorder in which the fetal prosencephalon (forebrain) fails to divide to allow formation of bilateral cerebral hemispheres. HPE is also one of the extreme manifestations of severe fetal alcohol spectrum defects (FASD) in human embryos and in animal models of FASD. [15] [16] [17] [18] [19] [20] Similarly, production of Shh in the floor plate of the neural tube regulates the development of neural components in the overlying basal plate, including progenitors of motor neurons.
12,21 FASD patients display delayed motor development and impaired fine-and gross-motor skills. 22 Varying degrees of motor retardation have been observed in up to 89% of humans having FASD. [23] [24] [25] Indeed, the diagnostic criteria for FASD include impaired fine motor skills. 26 Shh also has a proven role in neural crest morphogenesis, 27 and FASD frequently includes defects in neural crest-derived structures. Clearly, there is significant overlap between the tissues affected by alcohol exposure, and those tissues that depend on Shh signaling for proper development.
Post-translational modification of Shh by cholesterol 4 is a tightly regulated process that is necessary for the transportation and establishment of concentration gradients of the mature Shh ligand in developing embryos. 28 Sterol-and fatty acid-modified Shh proteins form soluble multimers that are packaged in micelles for long range transport. 29 Recent work has demonstrated that the activity and function of Shh protein varies significantly, depending upon the presence or absence of these modifications. 5 The roles played by cholesterol-modified Shh ligand in many facets of embryogenesis may account for some of the teratogenic effects of perturbed cholesterol biosynthesis in animal development. 30 Similar congenital defects occur in offspring of women who drink alcohol during pregnancy.
The teratogenic consequences of fetal exposure to alcohol are highly variable and include a spectrum of morphologic defects known as FASD. 31 Phenotypic abnormalities of FASD include neurological, craniofacial, cardiac, and limb malformations, as well as generalized growth deficits and mental retardation. 32 The mechanisms proposed to underlie the spectrum of birth defects caused by fetal alcohol exposure include: apoptosis, 33 cell adhesion defects, 34 accumulation of free radicals, 35 dysregulation of growth factors, 36 and altered retinoic acid biosynthesis. 37 Some simple and essential questions have not been well explained by these hypotheses, for instance, how one or, at most, a few social drinks, cause fetal defects, why alcohol preferentially induces defects targeting some organs and tissues and not others, or why the pattern of defects seen in FASD is predictable and reproducible.
Alcohol can also impair prechordal plate migration 38 and disrupt the formation and function of Spemann's Organizer, 39 a signaling center in gastrulating embryos that controls the patterning of the germ layers; the specific mechanisms that regulate axis pattern formation require highly evolutionarily conserved genetic pathways involving transcription regulatory circuitry and signal transduction pathways. 40 Shhcontaining vesicles contained within the organizer initiate a signal transduction pathway that plays a key role in embryonic patterning during development. 41 Therefore, genetic or environmental factors that inhibit Shh signaling during gastrulation can disrupt proper patterning of the embryo. Interestingly, embryos that are exposed to alcohol during gastrulation 38 have defects that are similar to those found in embryos that have defects in Hh signal transduction. 42 A similar phenotype develops in embryos with a genetic defect in sterol homeostasis, for example, Smith-Lemli-Opitz Syndrome 43 or that are exposed to cholesterol lowering agents. 44, 45 These observations suggest that FASD may result from alcohol-dependent inhibition of cholesterol modification of Shh.
Many genetic disorders can result in abnormal regulation of cholesterol biosynthesis, storage, and trafficking. However, ethanol ingestion may be far more common mechanism for disrupting cholesterol homeostasis. Ethanol causes an inhibition of HMG-CoA reductase activity, which results in decreased free cholesterol in the cells, and reduction in circulating cholesterol levels. [46] [47] [48] Acute ethanol exposure in perfused rat liver results in depletion of cholesterol in both liver homogenate and microsomes. 49 Ethanol specifically inhibits hepatic ACAT activity, which can lead to decreased cholesterol esters for transport in LDLs. 50 Thus, evidence from embryology, toxicology, and molecular biology indicates that a teratogenic mechanism underlying FASD links alcohol, cholesterol homeostasis, Shh signaling and cholesterol modification of functional Shh.
Several animal models have been to study FASD. The zebrafish model offers many advantages compared to insect and rodent models for alcohol and development studies: zebrafish are small in size, they have a large number of progeny, and they have rapid embryogenesis. This model has already been widely used in studies of developmental biology, genetics, gene function, signal transduction and high throughput drug screening. All of these characteristics make it an ideal model to delineate the molecular basis of the alcohol-induced birth defects.
We have shown that transient alcohol exposure during early development of zebrafish embryos causes dose-related inhibition of Hh signal transduction and produces a spectrum of permanent FASD-like defects. Alcohol-induced inhibition of Hh pathway activity parallels alcohol disruption of cholesterol homeostasis and decreased cholesterol-modification of the Shh ligand. Supplementing the alcohol-exposed embryos with cholesterol rescues the loss of Shh signal transduction, and prevents embryos from developing FASDlike morphologic defects.
MATERIALS AND METHODS
Alcohol, Cyclopamine, and AY-9944 Treatment Embryonic alcohol exposures were adapted from a previous report. 38 Embryos with chorions were exposed to six different concentrations of alcohol (eg, 0, 0.25, 0.5, 1.0, 1.5, and 2.0% (v/v)) in embryo medium. Embryos in sealed Petri dishes were exposed to alcohol for 6 h beginning at the dome stage (ie, 4.25 hours post-fertilization (hpf) or 30% epiboly stage) and were incubated at 28.51C. Immediately following alcohol exposure, embryos were harvested for analysis of Hh pathway activity, cholesterol content, or tissue alcohol concentration. The remaining embryos were washed and incubated in alcohol-free medium. Embryos were then harvested at 1, 2, or 4 days post-fertilization for survival and phenotypic analyses. Cyclopamine (11-deoxojervine) is naturally-occurring chemical that inhibits the Hh signaling pathway by functioning as an antagonist of Smo protein. AY9944, trans-1, 4 bis-(2-dichlorobenzylaminomethyl) cyclohexane dihydrochloride blocks cholesterol synthesis through inhibition of 7-dehydrocholesterol reductase. AY-9944 (7.5 mM, Sigma-Aldrich) and cyclopamine (10.0 mM, Calbiochem) were administered in the same manner as alcohol. Following treatment, embryos were washed and incubated in normal medium for up to 4 days postfertilization.
Alcian Blue Staining and Immunohistochemistry
Staining for skeletal structures was performed as previously described. 51 Immunohistochemistry is carried out with following primary antibodies (Hybridoma Bank, 1:10): MF20 to stain myocardium and facial muscles, S46 to identify ventricular myocardium, and F59 to identify slow muscle progenitors in the somites. The secondary antibodies were Alexa 568-conjugated goat anti-mouse IgG 2b and Alexa 488-conjugated goat anti-mouse IgG 2a (1:400, Molecular Probes). The embryos were mounted and imaged.
Measurement of Cholesterol Content
Following alcohol exposure, lipids were extracted from embryos (nX14) with chloroform-methanol (2:1) in duplicate. Cholesterol content was then measured by the Amplex Red Cholesterol Assay Kit (Invitrogen).
Measurement of Tissue Alcohol Concentration
Following alcohol exposure, embryos (n ¼ 38) were pooled from each treatment group in triplicate. An Alcohol Test Kit (Diagnostic Chemicals Limited) was used to determine the tissue alcohol concentrations in treated embryos.
RT-PCR and Real-Time Quantitative Analysis
Total RNA was extracted from embryos (n ¼ 10) with RNeasy kits (Qiagen). RT-PCR were performed using with primers (Supplementary Table 1) as described previously. 52 Immunoblot Total cellular protein was isolated as described previously 51 and cell membrane proteins were isolated using the Mem-PER(r) Eukaryotic Membrane Protein Extraction Reagent Kit (Pierce Biotechnology). Proteins (40 mg) in Laemmli buffer were then separated by 12% Tris-HCI SDS-polyacrylamide gel electrophoresis and transferred to a PVDF membrane. Membranes were blocked, washed, and exposed to primary antibodies (Santa Cruz Biotechnology) against Shh (N-19, Catalog number: sc-1194; dilution: 1:2500) and b-actin (1:1000). Signals were detected by Anti-goat HRP antibody (1:10 000, Amersham).
Gli-Luciferase Reporter Assay
The Gli-luciferase reporter assay was performed in replicate experiments of pooled embryos (n ¼ 15). Briefly, zebrafish embryos at the 1-2 cell stage were microinjected with 0.5 nl of Gli-BS-Firefly luciferase plasmid (60 ng nl
À1
) and Renilla luciferase plasmid (60 ng nl
, pRL-TK, Promega). Reporter activity was determined by using the Dual-Luciferase Reporter Assay System (Promega). Activity of the Firefly luciferase reporter was normalized to the activity of a Renilla luciferase internal control for transfection efficiency.
Cholesterol Microinjection
Embryos were microinjected at 1-2 cell stage with 0.2 nl of 5 mg ml À1 (10 pg) cholesterol (BioVision Inc.) with or without the two plasmids for the Gli-luciferase reporter assay. Embryos were allowed to develop and were then treated with alcohol as previously described. At 48 hpf embryos were analyzed.
RESULTS

Alcohol Exerts Teratogenic Effects in a Dose-and Stage-Specific Manner
We have chosen the zebrafish model to evaluate our hypothesis because it permits exposure to precise concentrations of alcohol during well-defined developmental time frames. We exposed zebrafish embryos to a range of alcohol concentrations (0, 0.25, 0.5, 1.0, 1.5, and 2.0% v/v in embryo medium at two different time windows during development. The first exposure window occurs from 1 to 2 cell stages to 3 hpf, and the second exposure window occurs between 4.25 and 10.25 hpf during the late blastula stage and the gastrula stage. Exposure to alcohol during the first exposure window is almost uniformly fatal. Fewer than 40% of the 897 embryos from this time frame that were treated with the lowest alcohol concentration (0.25%) survived to 48 hpf.
Embryos exposed to alcohol during the second exposure window had much better survival rates than those exposed during the zygote stage to the same levels of alcohol. During the late blastula-gastrula stage, survival of the exposed embryos was also dose-dependent. For example, o10% of 202 embryos exposed to 2% alcohol during this time frame were alive at 48 hpf, compared to a survival rate of over 90% for the 897 embryos exposed to 0.25% alcohol for 6 h during the same developmental time frame. We also performed more detailed analysis at 48 hpf by scoring alcohol effects in three categories: (a) dead, (b) alive with abnormal phenotype, or (c) alive without abnormal phenotype. As shown in Figure  1a , during the late blastula-gastrula stage, the phenotype at 48 hpf depended upon the dose of alcohol that embryos were exposed to. For example, 84% of the embryos exposed to 2% alcohol during the second exposure window survived through 48 hpf and exhibited abnormal morphology (see Figure 2 for illustrations of representative defects), while only 2.6% of the living embryos were phenotypically normal. This level of exposure was lethal for the remaining 13% of embryos. In contrast, 18% of the embryos exposed to 0.25% alcohol during the second exposure window were alive and had minimal abnormalities at 48 hpf; the majority (72.3%) were alive and had normal phenotypes and o10% failed to survive to the 48 hpf time point. The frequency of these alcohol-induced phenotypes has been characterized in Table 1 .
To assure that the alcohol-induced morphologic defects seen in our model do not merely reflect exposure to supraphysiologic concentrations of alcohol, we measured the alcohol concentrations in fetal tissue following alcohol exposures. Tissue alcohol concentrations in zebrafish embryos correspond to the exposed alcohol concentration in embryo medium 0.25-2.0% range from 0.71-7.4 mM or 0.003-0.034 g dl À1 (Figure 1b) . These alcohol concentrations can be achieved in the blood of a human being by consumption of one or, at most, a few social drinks.
Morphological Defects Induced by Fetal Alcohol
Exposure Recapitulate the Development Abnormities with Hh Signaling Defects As others have reported, 38 we found that alcohol-induced defects in zebrafish embryos recapitulated those that occurred in other species following fetal alcohol exposure. In a dose-dependent fashion, transient alcohol exposure for 6 h during gastrulation resulted in subsequent permanent phenotypic abnormalities while only a modest increase in the rate of embryo mortality was observed (Figure 1a) . By 48 hpf, a cumulative cranial-to-caudal phenotype was evident in embryos that were exposed to alcohol transiently during gastrulation (Figure 2 ). These embryos were growth retarded (Figure 2a) , and exhibited a dose-dependent spectrum of phenotypes that included neurological, craniofacial, cardiac, and body axis defects. Embryos exposed to the highest alcohol concentrations had overt HPE, cyclopia (complete or partial), pericardial edema, U-shaped somites and severely foreshortened tails (Figure 2a and b) . Comparisons performed between alcohol-treated embryos and embryos transiently treated with cyclopamine, a specific inhibitor of Hh signaling, or AY-9944, an inhibitor of cholesterol biosynthesis and transportation, during gastrulation revealed that embryos from all three groups had HPE and partial cyclopia, as well as underdevelopment of the craniofacial bones and muscles, and failure of the heart tube to loop (Figure 2c ). These observations support a role for defective Shh signaling in the pathogenesis of FASD and are consistent with the possibility that alcohol inhibits Shh activity by interfering with cholesterol modification of the cleaved 19 kDa protein.
Alcohol Disrupts Hh Pathway Activity without Significant Change of Shh Protein Expression, but Does Decrease Levels of Cholesterol-Modified Shh
To investigate this further, Shh signaling activity was directly measured by examining developing embryos that were microinjected with a Shh-responsive, Gli-BS luciferase reporter construct at the 1-2 cell stage. 53 Following alcohol exposure, both luciferase activity (Figure 3a) and the expression of Shh-regulated genes, such as Ptc, Gli1, and Nkx2.2 (Figure 3b ), decreased in a dose-related fashion. Real-time quantitative PCR analysis confirmed that there is a threshold for alcohol-induced inhibition of the expression of Shh target genes. While exposure to a very low alcohol concentration (0.25%) caused no significant change in the expression of Ptc or Gli1, Nkx2.2 expression decreased by about 50% under these conditions. In response to a 0.5% alcohol treatment, expression of these three Shh target genes decreased by from 1.3-to 1.9-fold, and alcohol concentrations ranging from 1.0 to 2.0% caused expression of those genes to decrease from 5-to 17-fold (Figure 3c) . In contrast to the results obtained 
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by RT-PCR, real-time quantitative PCR showed that Shh transcription decreased when embryos were exposed to alcohol concentrations higher than 1.0%. Notably, inhibition of Shh signaling occurred despite relatively stable levels of Shh protein from whole cell lysates (cytosolic and membrane). However, inhibition of Shh signaling was associated with a progressive loss of Shh from the cellular membrane protein fraction isolated from FASD embryos (Figure 3d ). Given that Shh must be covalently modified by cholesterol to anchor in plasma membranes, these results suggest that 
Alcohol Treatment Alters Cholesterol Homeostasis and Reduced Cholesterol Ester Content
As shown in Figure 3 , alcohol exposure during the late blastula-gastrula stage causes a dose-dependent reduction in membrane-associated Shh. Given that esterification of Shh by cholesterol drives its membrane localization, these results also suggest that alcohol exposure reduces cholesterol ester formation. We tested whether alcohol exposure impairs general sterol homeostasis during gastrulation by measuring cholesterol levels in whole embryo extracts. In a dose-related fashion, alcohol exposure resulted in a decrease in the total cholesterol content of the embryos (Figure 4 ). This was mostly due a reduction in total cholesterol esters that paralleled the dose-dependent decreases in cholesterol-modified Shh protein and Shh signaling activity (Figure 3a and b) , and correlated with a dose-dependent acquisition of alcohol-induced morphologic defects: the higher the dose the more severe and extensive the defects (Figure 2a and b) . Together with evidence that AY-9944 lowers cholesterol and produces similar defects (Figure 2c ), our findings suggest that alcohol interrupts cholesterol homeostasis and that depleted stores of cholesterol results in impaired cholesterol modification of Shh, leading to decreased Shh signaling, which causes a FASD-like phenotype.
Supplementation of Cholesterol Rescues Hh Signaling Defects Caused by Alcohol and Prevents Fetal Alcohol Induced Developmental Defects
To confirm the importance of this potential molecular mechanism for FASD, we performed rescue experiments in alcohol-exposed embryos. Supplemental cholesterol, Gli-BSFirefly luciferase plasmid, and Renilla luciferase plasmid were co-microinjected into 1-2 cell stage embryos, which were then treated with various alcohol concentrations during gastrulation. Subsequent studies showed that Gli-BS reporter activity was preserved at all doses of alcohol exposure in cholesterol-supplemented embryos (Figure 5a ). To determine whether recovery of Shh activity leads to the rescue of Hhdependent cell differentiation, we studied the slow muscle pioneer (MP) cells in somites 42 using the F59 antibody which specifically identifies these progenitors. 54 In untreated embryos, at 48 hpf, we observed an organized, V-shaped pattern of MP fibers with approximately 20 fibers per somite pair. Microinjection of 5% DMSO (the cholesterol dissolving vehicle) had no adverse effect on zebrafish development. In contrast, alcohol-exposed embryos had a disorganized, diffuse pattern of MP fibers at this time. The cholesterol-supplemented, alcohol-exposed embryos had a similar number and pattern of MP fibers as the untreated, wild-type embryos (Figure 5b) . Furthermore, most (94.8%) of the cholesterolsupplemented, alcohol-exposed embryos (n ¼ 58) appeared grossly normal, unlike 83.3% of the alcohol-exposed, unsupplemented embryos (n ¼ 96) that had FASD-like phenotypes (Figure 5c ). Thus, cholesterol supplementation rescues alcohol-inhibited Shh signaling, and prevents alcohol-induced defects at the molecular, cellular, and developmental levels.
DISCUSSION
In a number of previous studies, researchers have used zebrafish to determine alcohol-related effects on development. [55] [56] [57] [58] [59] We have extended these results by using this model to identify a novel molecular mechanism that may be responsible for alcohol's teratogenic effects, namely, alcoholinduced inhibition of the cholesterol modification of Shh, which subsequently inhibits Shh signal transduction; inhibition of this pathway appears to play the key role in the development of FASD pathogenesis.
As zebrafish lack placentas and develop ex utero, and alcohol dehydrogenases 60, 61 are not expressed in embryos at the time exposed to alcohol (ie from 4-10 hpf), Thus, the metabolites generated by oxidation of ethanol are not likely to be a major cause of the induced phenotypes. Even at very a Alcohol concentration in embryos medium at v/v (%), embryos were treated at the dome/30% epiboly stage (4.3 hpf) for 6 h, phenotype were analyzed at 48 hpf for HPE, cyclopia, and heart edema. Defective arch bones and shortened tails were analyzed at day 4 after fertilization by alcian blue staining.
b Cyclopia phenotypes include full and partial cyclopia that with separate, but more closely spaced eyes.
Alcohol and Shh-cholesterol modification Y-X Li et al low tissue concentration, alcohol may directly causes developmental defects, instead of alcoholic metabolites from maternal resource or the embryo. Direct measurements determined a range of alcohol concentration from 0.71-7.4 mM or 0.003-0.034 g dl À1 in fetal tissue under our experimental conditions. These alcohol concentrations are about 5.9-to 123-fold lower than blood alcohol levels that induce FASD in mice; 62 these concentrations are also 4.2-to 153-fold lower than the alcohol concentrations that induce cell apoptosis, 63 and retinoic acid deficiency 37 or that have antagonistic effects on growth factors. 36 Hence, relatively low concentrations of fetal tissue alcohol also can induce FASD-like defects. Blood alcohol concentrations in this range are achieved in a 55-kg female following the consumption of one 12-ounce beer. This may explain why alcohol is the most common teratogen responsible for human congenital defects, and suggests that there is no safe level of alcohol consumption during pregnancy.
The morphological phenotypes induced by alcohol in zebrafish recapitulate the FASD defects seen in other species. For instance, similar defects have also been reported in human embryos that have FASD: 23, 64 microcephaly in 84%, eye problems in 25%, cardiac developmental defects in 29%, various problems with truncal muscles and bones, including slack muscles in 58%, swallowing/feeding problems in 20%, hip deformities in 9%, pidgeon chest in 30%, concave chest in 7%, and spinal dimple in 44%. FASD patients also have craniofacial abnormalities such as facial anomalies (95%), small teeth (16%), cleft palate (7%), and overall growth retardation (98%). Thus, it seems that the ethanol-related developmental defects that we have observed in zebrafish embryos nicely parallel those observed in humans having FASD.
The evidence presented here and elsewhere 38, 65 consistently demonstrates that fetal alcohol exposure inhibits the transcription of Shh responsive genes. Notably, we found that total Shh protein level in the zebrafish embryonic tissues was not significantly changed by any of the tested alcohol exposures. However, the treated embryos exhibited FASD-like phenotypes and impaired Hh signal transduction, suggesting that defective Shh signaling is the key factor in the morphological defects induced by alcohol. Furthermore, we have now shown that the defect in Shh signal transduction is due to disruption of the post-translational cholesterol modification of Shh. This findings help to explain why over-expression of Shh mRNA alone does not consistently rescue alcohol-induced morphologic defects or the decrease in expression of Shh responsive genes. 38, 65 Here, we observed that supplementing a simple chemical, cholesterol rescues the alcohol-inhibited Hh signal transduction and prevents embryos from developing FASD-like morphologic defects. Recently, sterols were shown to directly activate the Shh signaling pathway through Smo. Cholesterol, or certain oxyterols, serve as Smo agonists. 66 This evidence suggests that cholesterol may also directly stimulate Smo to initiate Shh signal transduction, bypassing the pathway and rescuing alcohol-induced Shh-dependent development. It will be interesting to determine whether the same cholesterol supplementation strategy that rescues alcohol-exposed embryos might protect embryos from tetratogenicity caused by other environmental factors that induce cholesterol-related defects in Shh signaling.
The mature Shh peptide is doubly lipid-modified, having a cholesterol moiety at its C terminus, 4 and a palmitate attachment at Cys-24 of the N terminus. 67 The N-terminal lipid is required for inducing the differentiation of ventral forebrain neurons. 68 In contrast, in the absence of the Nlipid, the C-terminal lipid-containing Shh is sufficient to induce mouse digit duplication. 69 Mouse mutants have been created in which Shh lacks cholesterol modification, lacks palmitoylation, or lacks both types of lipid modification. Functional analysis of these mutants clearly demonstrated that both types of lipid modification are essential for regulating the range and shape of the Shh morphogen gradient during early development. 70, 71 For future direction, it remains to be determined whether the alcohol-induced defect in cholesterol modification influences N-terminal palmitoylation, or Shh cellular trafficking in lipid rafts, or affects the binding affinity of Shh to Ptc, or even the gradient shape and content of Shh.
Overall, we have shown that a simple post-translational modification defect of a key morphogen results in a complex congenital disease. This new insight into the molecular basis of FASD has far-reaching implications, and suggests novel prenatal interventions that might prevent FASD developmental defects.
